FMRP interacts with G-quadruplex structures in the 3 ′-UTR of its dendritic target shank1 mRNA

RNA Biology

Volumn 11, Issue 11, 2014, Pages 1364-1374

  Zhang, Yang ^a   Gaetano, Christian M ^a   Williams, Kathryn R ^b   Bassell, Gary J ^b   Mihailescu, Mihaela Rita ^a  

^a DUQUESNE UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

FMRP; Fragile X syndrome; G quadruplex; RGG box; Shank1 mRNA

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X MENTAL RETARDATION PROTEIN S500D; GUANINE QUADRUPLEX; MESSENGER RNA; PHOSPHOPROTEIN; SCAFFOLD PROTEIN; SHANK1 PROTEIN; SHANK1A PROTEIN; SHANK1B PROTEIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; NERVE PROTEIN; PROTEIN BINDING; SHANK1 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR STABILITY; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; PROTEIN RNA BINDING; RNA ANALYSIS; ALGORITHM; CHEMISTRY; CIRCULAR DICHROISM; DENDRITIC SPINE; FRAGILE X SYNDROME; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KINETICS; METABOLISM; PROTEIN SYNTHESIS; SPECTROFLUOROMETRY; THERMODYNAMICS;

3' UNTRANSLATED REGIONS; ALGORITHMS; CIRCULAR DICHROISM; DENDRITIC SPINES; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; G-QUADRUPLEXES; GENE EXPRESSION REGULATION; HUMANS; KINETICS; NERVE TISSUE PROTEINS; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; SPECTROMETRY, FLUORESCENCE; THERMODYNAMICS;

EID: 84923565310     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.1080/15476286.2014.996464     Document Type: Article

References (61)

1. Crawford, DC, Acuña, JM, Sherman, SL. FMR1 and the fragile X syndrome: human genome epidemiology review. Genetics in Medicine 2001, 3(5), 359-371; PMID:11545690; http://dx.doi.org/10.1097/ 00125817-200109000-00006
2. O' Donnell, WT, Warren, ST. A decade of molecular studies of fragile X syndrome. Annual review of neuroscience 2002, 25(1), 315-338; http://dx.doi.org/ 10.1146/annurev.neuro.25.112701.142909
3. Jin, P, Warren, ST. Understanding the molecular basis of fragile X syndrome. Human molecular genetics 2000, 9(6), 901-908; PMID:10767313; http://dx.doi. org/10.1093/hmg/9.6.901
4. Devys, D, Lutz, Y, Rouyer, N, Bellocq, JP, Mandel, JL. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nature genetics 1993, 4(4), 335-340; PMID:8401578; http://dx.doi.org/10.1038/ng0893-335
5. Bagni, C, Greenough, WT. From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome. Nature Reviews Neuroscience 2005, 6(5), 376-387; PMID:15861180; http://dx.doi.org/10.1038/nrn1667
6. Ashley, CT, Wilkinson, KD, Reines, D, Warren, ST. FMR1 protein: conserved RNP family domains andselective RNA binding. Science 1993, 262(5133), 563- 566; PMID:7692601; http://dx.doi.org/10.1126/ science.7692601
7. Siomi, H, Siomi, MC, Nussbaum, RL, Dreyfuss, G. The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein. Cell 1993, 74(2), 291-298; PMID:7688265; http://dx.doi.org/ 10.1016/0092-8674(93)90420-U
8. Narayanan, U, Nalavadi, V, Nakamoto, M, Pallas, DC, Ceman, S, Bassell, GJ, Warren, ST. FMRP phosphorylation reveals an immediate-early signaling pathway triggered by group I mGluR and mediated by PP2A. The Journal of Neuroscience 2007, 27(52), 14349- 14357; PMID:18160642; http://dx.doi.org/10.1523/ JNEUROSCI.2969-07.2007
9. Nalavadi, VC, Muddashetty, RS, Gross, C, Bassell, GJ. Dephosphorylation-induced ubiquitination and degradation of FMRP in dendrites: a role in immediate early mGluR-stimulated translation. The Journal of Neuroscience 2012, 32(8), 2582-2587; PMID:22357842; http:// dx.doi.org/10.1523/JNEUROSCI.5057-11.2012
10. Santoro, MR, Bray, SM, Warren, ST. Molecular mechanisms of fragile X syndrome: a twenty-year perspective. Annual Review of Pathology: Mechanisms ofDisease 2012, 7, 219-245; PMID:22017584; http:// dx.doi.org/10.1146/annurev-pathol-011811-132457
11. Penagarikano, O, Mulle, JG, Warren, ST. The pathophysiology of fragile x syndrome. Annu. Rev. Genomics Hum. Genet. 2007, 8, 109-129; PMID:17477822; http://dx.doi.org/10.1146/annurev. genom.8.080706.092249
12. Darnell, JC, Jensen, KB, Jin, P, Brown, V, Warren, ST, Darnell, RB. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 2001, 107(4), 489-499; PMID:11719189; http://dx.doi.org/10.1016/S0092-8674(01)00566-9
13. Menon, L, Mihailescu, MR. Interactions of the G quartet forming semaphorin 3F RNA with the RGG box domain of the fragile X protein family. Nucleic acids research 2007, 35(16), 5379-5392; PMID:17693432; http://dx.doi.org/10.1093/nar/gkm581
14. Hazel, P, Huppert, J, Balasubramanian, S, Neidle, S. Loop-length-dependent folding of G-quadruplexes. Journal of the American Chemical Society 2004, 126 (50), 16405-16415; PMID:15600342; http://dx.doi. org/10.1021/ja045154j
15. Davis, JT. G Quartets 40 Years Later: From 5 0 GMP to Molecular Biology and Supramolecular Chemistry. Angewandte Chemie International Edition 2004, 43(6), 668-698; PMID:14755695; http://dx.doi.org/ 10.1002/anie.200300589
16. Mergny, JL, De Cian, A, Ghelab, A, Sacca, B, Lacroix, L. Kinetics of tetramolecular quadruplexes. Nucleic acids research 2005, 33(1), 81-94; PMID:15642696; http://dx.doi.org/10.1093/nar/gki148
17. Williamson, JR, Raghuraman,MK,Cech, TR.Monovalent cation-induced structure of telomeric DNA: the G-quartet model. Cell 1989, 59(5), 871-880; PMID:2590943; http:// dx.doi.org/10.1016/0092-8674(89)90610-7
18. Joachimi, A, Benz, A, Hartig, JS. A comparison of DNA and RNA quadruplex structures and stabilities. Bioorganic & medicinal chemistry 2009, 17(19), 6811-6815; PMID:19736017; http://dx.doi.org/ 10.1016/j.bmc.2009.08.043
19. Willis, AE. Translational control of growth factor and proto-oncogene expression. The international journal of biochemistry & cell biology 1999, 31(1), 73-86; http://dx.doi.org/10.1016/S1357-2725(98)00133-2
20. Bryan, TM, Baumann, P. G-quadruplexes: from guanine gels to chemotherapeutics. Molecular biotechnology 2011, 49(2), 198-208; PMID:21416200; http:// dx.doi.org/10.1007/s12033-011-9395-5
21. Kumari, S, Bugaut, A, Huppert, JL, Balasubramanian, S. An RNA G-quadruplex in the 5 0 UTR of the NRAS proto-oncogene modulates translation. Nature chemical biology 2007, 3(4), 218-221; PMID:17322877; http://dx.doi.org/10.1038/nchembio864
22. Subramanian, M, Rage, F, Tabet, R, Flatter, E, Mandel, JL, Moine, H. G-quadruplex RNA structure as a signal for neurite mRNA targeting. EMBO reports 2011, 12(7), 697-704; PMID:21566646; http://dx. doi.org/10.1038/embor.2011.76
23. Drepper, C, Sendtner, M. A new postal code for dendritic mRNA transport in neurons. EMBO reports 2011, 12(7), 614-616; PMID:21681203; http://dx. doi.org/10.1038/embor.2011.119
24. Bassell, GJ, Warren, ST. Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 2008, 60(2), 201-214; PMID:18957214; http://dx.doi.org/10.1016/j.neuron. 2008.10.004
25. Darnell, JC, Mostovetsky, O, Darnell, RB. FMRP RNA targets: identification and validation. Genes, Brain and Behavior 2005, 4(6), 341-349; PMID:16098133; http://dx.doi.org/10.1111/j.1601-183X.2005.00144.x
26. Gundelfinger, ED, Boeckers, TM, Baron, MK, Bowie, JU. A role for zinc in postsynaptic density asSAMbly and plasticity. Trends in biochemical sciences 2006, 31 (7), 366-373; PMID:16793273; http://dx.doi.org/ 10.1016/j.tibs.2006.05.007
27. Okabe, S. Molecular anatomy of the postsynaptic density. Molecular and Cellular Neuroscience 2007, 34(4), 503-518; PMID:17321751; http://dx.doi.org/ 10.1016/j.mcn.2007.01.006
28. Sheng, M, Hoogenraad, CC. The postsynaptic architecture of excitatory synapses: a more quantitative view. Annu. Rev. Biochem. 2007, 76, 823-847; PMID:17243894; http://dx.doi.org/10.1146/annurev. biochem.76.060805.160029
29. Muddashetty, RS, Nalavadi, VC, Gross, C, Yao, X, Xing, L, Laur, O, Warren ST Bassell, GJ. Reversible inhibition of PSD-95 mRNA translation by miR-125a, FMRP phosphorylation, and mGluR signaling. Molecular cell 2011, 42(5), 673-688; PMID:21658607; http://dx.doi.org/10.1016/j.molcel.2011.05.006
30. Boeckers, TM, Bockmann, J, Kreutz, MR, Gundelfinger, ED. ProSAPShank proteins-a family of higher order organizing molecules of the postsynaptic density with an emerging role in human neurological disease. Journal of neurochemistry 2002, 81(5), 903-910; PMID:12065602; http://dx.doi.org/10.1046/j.1471- 4159.2002.00931.x
31. Jiang Y Elhers MD. Modelling autism by SHANK gene mutations in mice. Neuron 2013, 78(1), 8-27; PMID:23583105; http://dx.doi.org/10.1016/j. neuron.2013.03.016
32. Böckers, TM, Segger-Junius, M, Iglauer, P, Bockmann, J, Gundelfinger, ED, Kreutz, MR, Richter D, Kindler S, Kreienkamp, HJ. Differential expression and dendritic transcript localization of Shank family members: identification of a dendritic targeting element in the 3 0untranslated region of Shank1 mRNA. Molecular and Cellular Neuroscience 2004, 26(1), 182-190; PMID:15121189; http://dx.doi.org/10.1016/j. mcn.2004.01.009
33. Roussignol, G, Ango, F, Romorini, S, Tu, JC, Sala, C, Worley, PF, Bockaert J Fagni, L. Shank expression is sufficient to induce functional dendritic spine synapses in aspiny neurons. The Journal of neuroscience 2005, 25(14), 3560-3570; PMID:15814786; http://dx.doi. org/10.1523/JNEUROSCI.4354-04.2005
34. Sala, C, Piëch, V, Wilson, NR, Passafaro, M, Liu, G, Sheng, M. Regulation of dendritic spine morphology and synaptic function by Shank and Homer. Neuron 2001, 31(1), 115-130; PMID:11498055; http://dx. doi.org/10.1016/S0896-6273(01)00339-7
35. Schütt, J, Falley, K, Richter, D, Kreienkamp, HJ, Kindler, S. Fragile X mental retardation protein regulates the levels of scaffold proteins and glutamate receptors in postsynaptic densities. Journal of Biological Chemistry 2009, 284(38), 25479-25487; PMID:19640847; http://dx.doi.org/10.1074/jbc.M109.042663
36. Darnell, JC, Van Driesche, SJ, Zhang, C, Hung, KY S, Mele, A, Fraser, CE, Stone EF Darnell, RB. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 2011, 146(2), 247-261; PMID:21784246; http://dx.doi.org/10.1016/j. cell.2011.06.013
37. Fürtig, B, Richter, C, Wöhnert, J, Schwalbe, H. NMR spectroscopy of RNA. Chembiochem 2003, 4(10), 936-962; PMID:14523911; http://dx.doi.org/ 10.1002/cbic.200300700
38. Dapić, V, Abdomerović, V, Marrington, R, Peberdy, J, Rodger, A, Trent, JO, Bates, PJ. Biophysical and biological properties of quadruplex oligodeoxyribonucleotides. Nucleic acids research 2003, 31(8), 2097-2107; PMID:NOT-FOUND; http://dx.doi.org/10.1093/ nar/gkg316
39. Williamson, JR. G-quartet structures in telomeric DNA. Annual review of biophysics and biomolecular structure 1994, 23(1), 703-730; PMID:7919797; http://dx.doi. org/10.1146/annurev.bb.23.060194.003415
40. Hardin, CC, Perry, AG, White, K. Thermodynamic and kinetic characterization of the dissociation and assembly of quadruplex nucleic acids. Biopolymers 2000, 56(3), 147-194; PMID:11745110; http://dx. doi.org/10.1002/1097-0282(2000/2001) 56:3%3c147::AID-BIP10011%3e3.0.CO;2-N
41. Mergny, JL, Phan, AT, Lacroix, L. Following G-quartet formation by UV-spectroscopy. FEBS letters 1998, 435 (1), 74-78; PMID:9755862; http://dx.doi.org/ 10.1016/S0014-5793(98)01043-6
42. Kelley, SO, Barton, JK. Electron transfer between bases in double helical DNA. Science 1999, 283(5400), 375-381; http://dx.doi.org/10.1126/science.283.5400.375
43. Blice-Baum, A, Mihailescu, R. The Different FMRP Isoforms Bind with High Affinity to the G-Quadruplex formed by the FMRP mRNA. Biophysical Journal 2013, 104, 418; PMID:24249225; http://dx.doi.org/ 10.1016/j.bpj.2012.11.2331
44. Bole, M, Menon, L, Mihailescu, MR. Fragile X mental retardation protein recognition of G quadruplex structure per se is sufficient for high affinity binding to RNA. Molecular BioSystems 2008, 4(12), 1212-1219; PMID:19396385; http://dx.doi.org/10.1039/b812537f
45. Menon, L, Mader, SA, Mihailescu, MR. Fragile X mental retardation protein interactions with the microtubule associated protein 1B RNA. Rna 2008, 14(8), 1644-1655; PMID:18579868; http://dx.doi.org/ 10.1261/rna.1100708
46. Zanotti, KJ, Lackey, PE, Evans, GL, Mihailescu, MR. Thermodynamics of the fragile X mental retardation protein RGG box interactions with G quartet forming RNA.Biochemistry 2006, 45(27), 8319-8330; PMID:16819831; http://dx.doi.org/10.1021/bi060209a
47. Antar, LN, Bassell, GJ. Sunrise at the synapse: the FMRP mRNP shaping the synaptic interface. Neuron 2003, 37(4), 555-558; PMID:12597853; http://dx. doi.org/10.1016/S0896-6273(03)00090-4
48. Jin, P, Warren, ST. New insights into fragile X syndrome: from molecules to neurobehaviors. Trends in biochemical sciences 2003, 28(3), 152-158; PMID: AMBIGUOUS; http://dx.doi.org/10.1016/S0968- 0004(03)00033-1
49. Veneri, M, Zalfa, F, Bagni, C. FMRP and its target RNAs: fishing for the specificity. Neuroreport 2004, 15 (16), 2447-2450; PMID:15538171; http://dx.doi.org/ 10.1097/00001756-200411150-00002
50. Ceman, S, O' donnell, WT, Reed, M, Patton, S, Pohl, J, Warren, ST. Phosphorylation influences the translation state of FMRP-associated polyribosomes. Human molecular genetics 2003, 12(24), 3295-3305; PMID:14570712; http://dx.doi.org/10.1093/hmg/ddg350
51. Tarrant, MK, Cole, PA. The chemical biology of protein phosphorylation. Annual review of biochemistry 2008, 78, 797-825; http://dx.doi.org/10.1146/ annurev.biochem.78.070907.103047
52. Evans, TL, Blice-Baum, AC, Mihailescu, MR. Analysis of the Fragile X mental retardation protein isoforms 1,2 and 3 interactions with the G-quadruplex forming semaphorin 3F mRNA. Molecular BioSystems 2012, 8 (2), 642-649; PMID:22134704; http://dx.doi.org/ 10.1039/c1mb05322a
53. Blice-Baum, AC, Mihailescu, MR. Biophysical characterization of G-quadruplex forming FMR1 mRNA and of its interactions with different fragile X mental retardation protein isoforms. RNA 2014, 20(1), 103-114; PMID:24249225; http://dx.doi.org/10.1261/ rna.041442.113
54. Li, Y, Tang, W, Zhang, LR, Zhang, CY. FMRP regulates miR196a-mediated repression of HOXB8 via interaction with the AGO2 MID domain. Molecular BioSystems 2014, 10(7), 1757-1764; PMID:24727796; http://dx. doi.org/10.1039/c4mb00066h
55. Edbauer, D, Neilson, JR, Foster, KA, Wang, CF, Seeburg, DP, Batterton, MN, . . . Sheng, M. Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron 2010, 65(3), 373-384; PMID:20159450; http://dx.doi.org/ 10.1016/j.neuron.2010.01.005
56. Laggerbauer, B,Ostareck,D,Keidel, EM,Ostareck-Lederer, A, Fischer, U. Evidence that fragileXmental retardation protein is a negative regulator of translation. Human molecular genetics 2001, 10(4), 329-338; PMID:11157796; http://dx. doi.org/10.1093/hmg/10.4.329
57. Evans, TL, Mihailescu, MR. Recombinant bacterial expression and purification of human fragile X mental retardation protein isoform 1. Protein expression and purification 2010, 74(2), 242-247; PMID:20541608; http://dx.doi.org/10.1016/j.pep.2010.06.002
58. Deʇerli, N, Akpinar, MA. A novel concentration method for concentrating solutions of protein extracts based on dialysis techniques. Analytical biochemistry 2001, 297(2), 192-194; http://dx.doi.org/10.1006/abio.2001.5335
59. Gasteiger, E, Gattiker, A, Hoogland, C, Ivanyi, I, Appel, RD, Bairoch, A. ExPASy: the proteomics server for indepth protein knowledge and analysis. Nucleic acids research 2003, 31(13), 3784-3788; PMID:12824418; http://dx.doi.org/10.1093/nar/gkg563
60. Valverde, R, Pozdnyakova, I, Kajander, T, Venkatraman, J, Regan, L. Fragile X mental retardation syndrome: structure of the KH1-KH2 domains of fragile X mental retardation protein. Structure 2007, 15(9), 1090-1098; PMID:17850748; http://dx.doi.org/ 10.1016/j.str.2007.06.022
61. Piotto, M, Saudek, V, Sklenář, V. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. Journal of biomolecular NMR 1992, 2(6), 661-665; PMID:1490109; http://dx.doi. org/10.1007/BF02192855